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Abstract
We describe a case demonstrating Magnetic
Resonance (MR) imaging findings in association with
Metronidazole (Flagyl) toxicity. MRI brain showed abnormal
signal intensity involving dentate nuclei of cerebellum
bilaterally symmetrical. The diagnosis of metronidazole
toxicity was made by the MR imaging findings and supported
clinically. In hospital, course of treatment drug was
discontinued.
Patient
improved
clinically
with
discontinuation of metronidazole. No follow-up MR imaging
was obtained. In this report, we present a case depicting MR
imaging changes within the dentate nuclei of cerebellum.
Keywords: Central Nervous System, Metronidazole
Toxicity, Magnetic Resonance Imaging.

Introduction
Metronidazole is a common antimicrobial agent
used in the treatment of anaerobic and protozoal infections.
Metronidazole induced encephalopathy (MIE) is a rare
toxic encephalopathy caused by the drug metronidazole.
Metronidazole is believed to penetrate Cerebro Spinal
Fluid (CSF) and the central nervous system (CNS) easily.1
The incidence of MIE is unknown.2 Metronidazole toxicity

can involve central and peripheral nervous system
especially at dosages exceeding 2g/day for prolonged
periods.2,3
Ahmed et al first described the imaging findings of
metronidazole toxicity in a 45 year old patient who
developed nausea, vomiting, vertigo, dysarthria, and
confusion after consuming 35g metronidazole over a 30 day
course of therapy. MR imaging of the brain at this point
showed symmetric abnormal signal intensity within
supratentorial white matter including the corpus callosum
and within the cerebellum and cerebellar deep nuclei.
Following discontinuation of metronidazole, the patient's
symptoms resolved rapidly. Repeat MR imaging of the
brain demonstrated near complete resolution of findings 6
weeks after discontinuation of metronidazole.4

Case Report
A 41 year old male patient with addiction of hashish,
charas, alcohol and cigarettes was referred for MRI of the
brain after complaints of difficulty in walking for 1 week,
vertigo and dizziness for 1 day, history of fall 1 day back.
According to patient he was in his usual state of health 10
days back when he developed numbness in feet below

Figure: (a) T1-weighted Axial MR image show hypointense signal in bilateral dentate nuclei of cerebellum. (b) T2- weighted Axial MR image show symmetric hyperintense signal
in dentate nuclei. (c) FLAIR image demonstrate hyperintense signal. (d) Post contrast T1-weighted Axial image show no abnormal enhancement. (e) Diffusion weighted image
demonstrate hyperintense signal in dentate nuclei of cerebellum bilaterally.
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ankles and was unable to maintain a balance. Then he
developed slurred speech. He had history of Metronidazole
use for chronic loose motions. He took 1200 mg/day
metronidazole for 4 months. On examination Romberg sign
was positive, with slurring of speech and upgoing plantars
bilaterally. Bulk, tone, power and reflexes were normal. His
Electromyography and nerve conduction studies were
abnormal. The findings were suggestive of mild sensory,
motor predominantly sensory axonal neuropathy.
His MRI brain was done which showed abnormal
signal intensity involving dentate nuclei of cerebellum
bilaterally symmetrical. The signal intensity was
hypointense on T1-and hyperintense on T2 and FLAIR
sequences. After administration of intravenous Gadolinium,
there was no enhancement, as seen in Figure-1. Based on
these findings the differential diagnosis of metabolic
encephalopathy (eg Metronidazole encephalopathy (eg
West Nile) was suggested. In hospital treatment drug was
discontinued. Patient improved clinically with
discontinuation of metronidazole. No follow-up MR
imaging was obtained.

Discussion
Serious neurological side effects of metronidazole
toxicity include peripheral neuropathy, ataxic gait,
dysarthric speech, convulsive seizures and encephalopathy.3
The mechanism of metronidazole toxicity has not been
elucidated. The signal intensity changes observed on the
diffusion weighted images most likely represent interstitial
oedema. Ahmed et al4 speculated that, because of the
reversibility of the MR imaging changes, the cause of the
changes associated with acute toxic insult were most likely
due to "axonal swelling with increased water content." not
demyelination. The typical locations of lesions by MR
imaging in patients with MIE are the cerebellar dentate
nuclei, midbrain (tectum, red nucleus, tegmentum around
periaqueductal gray matter), dorsal pons, dorsal medulla,
and corpus callosum (splenium); and these were always
bilateral and symmetric. Uncommon locations were the
inferior olivary nucleus and the white matter of the cerebral
hemispheres.5 Although MR imaging findings of bilateral
involvement of the dentate nuclei are a very characteristic
feature of MIE, the differential diagnosis of T2 hyperintense

844

lesions of the bilateral cerebellar dentate nuclei in patients
with symptoms of acute encephalopathy includes methyl
bromide intoxication,6 maple syrup urine disease7 and
enteroviral encephalomyelitis.8
Horlen et al9 reported imaging findings of presumed
metronidazole toxicity in a 35 year old male patient with
liver cirrhosis who had consumed greater than 60 gram
metronidazole over a 55 day period and developed ataxia,
disorientation and peripheral neuropathy. MR imaging of
the brain demonstrated abnormal symmetric hyperintense
T2 signal intensity involving the dentate nuclei and inferior
basal ganglia. This patients symptoms also resolved with
discontinuation of metronidazole. No follow-up imaging
was obtained.
In our case, there was symmetrically increased T2
signal intensity in the dentate nuclei of cerebellum. Patient
improved clinically with discontinuation of metronidazole.
No follow-up MR imaging was obtained.

Conclusion
This case helps to characterize the changes
associated with metronidazole toxicity. MR imaging is
suggestive of metronidazole toxicity in clinically suspected
cases by demonstrating the presence of increased T2 signal
intensity in the deep nuclei.
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